by Amanda Kabage | May 26, 2020
Development of GMP protocols began at MCT. Our program was working in collaboration with a start-up company called NuQure, which later became CIPAC, then Crestovo, and ultimately Finch Therapeutics. Share this:Click to share on Twitter (Opens in new window)Click to...
by Amanda Kabage | May 26, 2020
Our first FMT was completed by Dr. Khoruts The donor was the patient’s husband. Click here to find the case report describing this patient, which contained the first documentation of engraftment of donor microbiota. Published in May 2010 in the Journal of...
by Amanda Kabage | May 26, 2020
On this day, the FDA workshop classified FMT as a drug and a biologic. Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to email a link to a friend (Opens in...
